The "Rising Stars in Drug Metabolism and Transport 2025/2026" highlights the groundbreaking work of early-career researchers ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
The convergence of genomics, systems biology, and artificial intelligence is transforming the landscape of drug discovery. Modern genomic technologies now ...
TriLink BioTechnologies senior scientist Dr Cody Palumbo discusses the blockers to manufacturing mRNA-based gene editing ...
In this interview, Karl Box shows how particle drift analysis with flux techniques enhances oral drug absorption in pharmaceutical research. Can you tell us about Pion’s Rainbow Dynamic Dissolution ...
GlobalData on MSN
Regeneron and Tessera join forces to forge in vivo AATD gene therapy
Regeneron Pharmaceuticals has teamed up with Tessera Therapeutics to develop and commercialise Tessera’s rare disease in vivo ...
Kelonia Therapeutics only started human testing of its in vivo CAR-T therapy for multiple myeloma in August, but already has ...
11don MSN
Rejuvenating the blood: New pharmacological strategy targets RhoA in hematopoietic stem cells
Aging is defined as the deterioration of function over time, and it is one of the main risk factors for numerous chronic ...
ONC001 is a first-in-class antibody-drug conjugate (ADC) designed to uniquely target CD64, a myeloid-restricted receptor pervasively expressed in CMML and M4/M5 acute myeloid leukemia, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback